Respira Therapeutics Announces Investment And Relocation Of Headquarters And Technical Laboratory To Albuquerque, NM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALBUQUERQUE, N.M., Dec. 18, 2013 (GLOBE NEWSWIRE) -- Respira Therapeutics, Inc. (Respira) (http://www.respiratherapeutics.com), announced today that it recently closed on an investment from Santa Fe, New Mexico-based venture capital funds Sun Mountain Capital and Cottonwood Technology Fund, as well as private individuals. Brian Birk, Managing Partner of Sun Mountain Capital, was elected to the Respira Therapeutics, Inc. Board of Directors as part of the transaction. “Respira is very pleased to welcome Sun Mountain as a new investor and for the continuing support and confidence of Cottonwood in our future success. The funds raised in this round will be used to transition Respira from an inhaler technology-based company into a pharmaceutical development company targeting drug / inhaler products used for the treatment of important diseases. We have relocated our headquarters from Santa Fe, NM and our technical laboratory from Austin, TX, both to Albuquerque, New Mexico, where our initial inhaler technology was invented at the University of New Mexico”, said Bob Curtis, Respira Therapeutics CEO.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC